98
Participants
Start Date
April 30, 2006
Study Completion Date
November 30, 2009
Goserelin acetate
3.6 mg intramuscular depot injection given every 4 weeks
Goserelin acetate
10.8 mg intramuscular depot injection given every 12 weeks
Research Site, Prague
Research Site, Arkhangelsk
Research Site, Belgorod
Research Site, Kaliningarad
Research Site, Kazan, Tatarstan
Research Site, Moscow
Research Site, Ryazan
Research Site, Saint Petersburg
Research Site, Yaroslavl
Research Site, Dnipropetrovsk
Research Site, Donetsk
Research Site, Kharkiv
Research Site, Odesa
Research Site, Uzhhorod
Lead Sponsor
AstraZeneca
INDUSTRY